Related references
Note: Only part of the references are listed.Protein-engineered molecules carrying GAD65 epitopes and targeting CD35 selectively down-modulate disease-associated human B lymphocytes
I. K. Manoylov et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2019)
Complement Receptor Type 1 (CR1, CD35), the Inhibitor of BCR-Mediated Human B Cell Activation, Differentially Regulates TLR7, and TLR9 Induced Responses
Bernadett Macsik-Valent et al.
FRONTIERS IN IMMUNOLOGY (2019)
CD69: from activation marker to metabolic gatekeeper
Danay Cibrian et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2017)
The versatile functions of complement C3-derived ligands
Anna Erdei et al.
IMMUNOLOGICAL REVIEWS (2016)
FHR3 Blocks C3d-Mediated Coactivation of Human B Cells
Denise Buhlmann et al.
JOURNAL OF IMMUNOLOGY (2016)
Complement Receptor Type 1 Suppresses Human B Cell Functions in SLE Patients
Mariann Kremlitzka et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2016)
CD21 and CD19 deficiency: Two defects in the same complex leading to different disease modalities
Marjolein W. J. Wentink et al.
CLINICAL IMMUNOLOGY (2015)
Complement receptor type 1 (CR1, CD35) is a potent inhibitor of B-cell functions in rheumatoid arthritis patients
Mariann Kremlitzka et al.
INTERNATIONAL IMMUNOLOGY (2013)
Human complement receptor 2 (CR2/CD21) as a receptor for DNA: Implications for its roles in the immune response and the pathogenesis of systemic lupus erythematosus (SLE)
Rengasamy Asokan et al.
MOLECULAR IMMUNOLOGY (2013)
Genetic CD21 deficiency is associated with hypogammaglobulinemia
Jens Thiel et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Elimination of autoreactive B cells in humanized SCID mouse model of SLE
Nikola S. Kerekov et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Human complement receptor type 2 (CR2/CD21) transgenic mice provide an in vivo model to study immunoregulatory effects of receptor antagonists
Liudmila Kulik et al.
MOLECULAR IMMUNOLOGY (2011)
Unique properties of memory B cells of different isotypes
Tomohiro Kurosaki et al.
IMMUNOLOGICAL REVIEWS (2010)
Complement Receptor 1: Disease associations and therapeutic implications
Rohan Khera et al.
MOLECULAR IMMUNOLOGY (2009)
Uncoupling CD21 and CD19 of the B-cell coreceptor
Robert A. Barrington et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
An antibody-based construct carrying DNA-mimotope and targeting CR1(CD35) selectively suppresses human autoreactive B-lymphocytes
Elisaveta Voynova et al.
IMMUNOLOGY LETTERS (2008)
Comparative functional evolution of human and mouse CR1 and CR2
Amanda C. Jacobson et al.
JOURNAL OF IMMUNOLOGY (2008)
Calcium signalling and cell-fate choice in B cells
Andrew M. Scharenberg et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Complement receptors CD21 and CD35 in humoral immunity
Ramon Roozendaal et al.
IMMUNOLOGICAL REVIEWS (2007)
Involvement of NFAT1 in B cell self-tolerance
Robert A. Barrington et al.
JOURNAL OF IMMUNOLOGY (2006)
Coligation of the B cell receptor with complement receptor type 2 (CR2/CD21) using its natural ligand C3dg: Activation without engagement of an inhibitory signaling pathway
T Lyubchenko et al.
JOURNAL OF IMMUNOLOGY (2005)
Role of complement-binding CD21/CD19/CD81 in enhancing human B cell protection from fas-mediated apoptosis
PKA Mongini et al.
JOURNAL OF IMMUNOLOGY (2003)
Complement receptor type 1 (CD35) mediates inhibitory signals in human B lymphocytes
M Józsi et al.
JOURNAL OF IMMUNOLOGY (2002)
Generation of recombinant human C3dg tetramers for the analysis of CD21 binding and function
SE Henson et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2001)
Share Paper
